Akari Therapeutics (Nasdaq: AKTX) announced the appointment of Robert Ward to its Board of Directors. Mr. Ward brings over twenty-five ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE